Next Article in Journal
Construction of a Luminescent Cadmium-Based Metal–Organic Framework for Highly Selective Discrimination of Ferric Ions
Next Article in Special Issue
Structural Design, Synthesis and Antioxidant, Antileishmania, Anti-Inflammatory and Anticancer Activities of a Novel Quercetin Acetylated Derivative
Previous Article in Journal
Direct Photoexcitation of Benzothiazolines: Acyl Radical Generation and Application to Access Heterocycles
Previous Article in Special Issue
Active Flavonoids from Colubrina greggii var. greggii S. Watson against Clinical Isolates of Candida spp.
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 26
Issue 22
10.3390/molecules26226844
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Insight into Potential Anticancer Activity of Algal Flavonoids: Current Status and Challenges

by
Umme Tamanna Ferdous
1 and
Zetty Norhana Balia Yusof
1,2,3,*
1
Aquatic Animal Health and Therapeutics Laboratory (AquaHealth), Institute of Bioscience, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia
2
Department of Biochemistry, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia
3
Bioprocessing and Biomanufacturing Research Complex (BBRC), Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(22), 6844; https://doi.org/10.3390/molecules26226844
Submission received: 14 August 2021 / Revised: 5 September 2021 / Accepted: 8 September 2021 / Published: 13 November 2021
(This article belongs to the Special Issue Flavonoids and Their Disease Prevention and Treatment Potential 2021)
Browse Figures
Versions Notes

Abstract

:
Flavonoids are some of the most precious phytochemicals, believed to be found largely in terrestrial plants. With the advancement of phytochemical research and marine bioprospecting, flavonoids have also been reported by the research of microalgae and macroalgae. High growth rate with minimal nutritional and growth requirement, saving arable land and rich metabolic profile make microalgae an excellent repertoire of novel anticancer compounds, such as flavonoids. In addition, marine algae, especially seaweeds contain different types of flavonoids which are assumed to have unique chemical structures and bioactivities than their terrestrial counterparts. Flavonoids are not only good antioxidants but also have the abilities to kill cancer cells by inducing apoptosis and autophagy. However, the study of the anticancer properties of flavonoids is largely limited to terrestrial plants. This review offers an insight into the distribution of different classes of flavonoids in eukaryotic microalgae, cyanobacteria and seaweeds with their possible anticancer activities. In addition, extraction and purification methods of these flavonoids have been highlighted. Finally, prospects and challenges to use algal flavonoids as anticancer agents have been discussed.

Graphical Abstract

1. Introduction

Cancer is ranked as the second-highest cause of death and accounts for about 10 million death in 2020 [1]. Based on the severe negative effects, chemo-resistance, high expenditure and scarcity of novel anticancer compounds, anticancer drug discovery is now more inclined to the investigation of natural sources. About eighty percent of all approved chemotherapeutics and fifty percent of all drugs are derived from natural origin. Natural drugs are accepted as a safer option than synthetic drugs because of their presence in the human diet and broad availability. Furthermore, natural drugs have reduced side effects and the potential to target various tumorigenesis-related signaling pathways. Considering all of these advantages, natural products research is burgeoning to search for novel anticancer compounds not only from terrestrial plants and microorganisms but also from marine organisms [2]. Marine organisms are offering a huge array of pharmaceutically important natural products that can be used to treat different kinds of human diseases, especially cancer. The chemical structures of marine-derived bioactive compounds are unique and highly diversified. Marine organisms show novel molecular scaffolds than terrestrial products [3]. Currently, a total of 14 marine-derived drugs are available on the market and 9 of them are used for cancer therapy. Another 19 compounds from the marine organisms are in different phases of cancer clinical trials. The anticancer compounds derived from marine compounds mainly come from mollusk/cyanobacterium, sponge, tunicate, bacterium, fungus and sea animals. Mollusk/cyanobacteria account for 64% of anticancer drugs [4]. Four anticancer drugs are already on the market from marine cyanobacteria species. Several other anticancer drug candidates from cyanobacteria species are in phase I–III clinical trials and also in preclinical trials. Eukaryotic microalgae are also under-exploration for discovering anticancer drug leads or fractions, as many of these eukaryotic microalgae are traditionally used as food and feed [5]. Marine microalgae are rich sources of pharmaceutically important bioactive compounds, like carotenoids, phenolics, flavonoids, fatty acids, alkaloids and other compounds. The advantages of using microalgae in drug discovery include their short generation time, metabolic plasticity, no competition for the arable land, their growing capacity irrespective of any season and less amount of special nutritional requirement to grow [6]. In terms of bioactivity and amount of phytochemicals, microalgae are richer than terrestrial plants [7]. For example, microalgae can produce more carotenoids, such as lutein, astaxanthin, than higher plants. Moreover, these carotenoids can be harvested in a less labor-intensive way and with low cost, in comparison to higher plants [8]. In addition, marine microalgae are assumed to produce unique metabolites with extensive chemical diversity, as they are facing extreme environments more often, like high salinity or temperature [3]. Microalgae and macroalgae are also rich sources of flavonoids [9].
Flavonoids are the most common plant polyphenols that are incorporated into our diet abundantly. Their complex molecular structures are related to biological functions in the human body. Plant flavonoids are extensively studied for their anticancer activities, along with other biological functions (Figure 1). Flavonoids derived from higher plants are successful in killing cancer cells and some of them are in different phases of clinical trials. A total of twenty-two Phase II clinical trials and one Phase III clinical trial investigated flavonoids alone or combined with other therapeutics either on hematopoietic/lymphoid or solid tumors. The most commonly tested flavonoid was Flavopiridol [10]. Though plant-derived flavonoids are under developing for new cancer drug, algal flavonoids are still limited to detection. No remarkable data is evident for their anticancer activity. However, their high flavonoid content and the prospect of having a unique flavonoid class make them promising sources of these compounds as anticancer agents (Table 1). This review, therefore, highlights the presence and quantity of flavonoids in different algal sources and possible anticancer activities.

2. Flavonoids

Flavonoids are a large group of polyphenolic metabolites which is widely dispersed throughout the plant species. Among many of the plant pigments, flavonoids are classed as edible. They are derived from derivatives of 2-phenyl-benzo-γ-pyrone [41]. Flavonoids have a common flavan structure that is a 15-carbon phenylpropanoid chain (C6-C3-C6), which is assembled into two aromatic rings and linked with another O2 containing pyrene ring. This basic structure is changed through oxidation and also modified in substituents to the pyrene ring that leads to the formation of other flavonoid classes [42]. Two aromatic rings are condensed to form a chalcone. Cyclization of chalcone forms flavanone which is the primary compound for the synthesis of other classes of flavonoids. Flavonoids are categorized into six different types. Flavanols (catechin, epicatechin, epigallocatechin), Flavanones (naringenin and hesperetin), Flavonols (quercetin, kaempferol or myricetin), Isoflavones (genistein and daidzein), Flavones (apigenin and luteolin) and Anthocyanidins are the groups (Figure 2) found in plant and algae [41].

3. Algal Flavonoids

Flavonoids are widespread in algae and the concentration of flavonoids can be further increased through different manipulation or enhancement techniques. For example, increased salt concentration has a significant effect on the accumulation of phenolics and flavonoids. The growth of cyanobacterial species Plectonema boryanum, Anabaena doliolum and Oscillatoria acuta were decreased when treated with high NaCl concentration but the accumulation of rutin was increased [13]. Metal stress can also help in the accumulation of flavonoids in microalgae. Dunaliella tertiolect has been reported to have increased catechin and epicatechin with an augmented amount of copper and these flavonoids are thought to be acted as a protector of microalgae cells from metal toxicity. The extracts containing these flavonoids also showed antioxidant activity [19]. With the increased concentration of nitrate and growth factor L-phenylalanine, Spirulina maxima showed accumulation of a higher amount of flavonoids, such as quercetin and kaempferol. The presence of these flavonoids along with other phenolics gave antioxidative protection against lipid peroxidation of hepatic microsomes in rats which were induced by carbon tetrachloride, an oxidizing agent. The results were comparable to the commercial antioxidant BHT and BHA [43]. Yadavalli et al. also reported the accumulation of flavonoids, like quercetin and catechin, in Chlorella vulgaris under nitrate-stressed-condition with supplementation with L-phenylalanine. Depletion of nitrate in the media upregulates the synthesis of flavonoids and the rate has been accelerated after the addition of L-phenylalanine due to its direct link in the flavonoid synthesis pathway [44]. In Leptolyngbya sp., catechin, apigenin, naringenin, luteolin and luteolin-7-glucoside were found to be the most common flavonoids. Among them, naringenin was the highest, 4.1 ± 0.01 mg/g [27].
Singh et al. investigated twenty terrestrial cyanobacteria species and detected three main flavonoids namely, quercetin, kaempferol and rutin. Rutin was found at highest level in Microcheate tenera (29.4 ± 0.7 µg/g) and the lowest amount in Chroococcus sp. (1.4 ± 0.3 µg/g) whereas quercetin was found mostly in Nostoc ellipsosporum (23.8 ± 1.03 µg/g) but least amount was detected in Westiellopsis prolific (3.7 ± 0.5 µg/g). Kaempferol was found in the highest amount in M. tenera and W. prolific, whereas Phormidium tenue was the cyanobacteria that produced the lowest amount of kaempferol [14].
Goiris et al. investigated the major flavonoid contents in different microalgae species. The frequently found flavonoids in the studied microalgae were naringenin, apigenin, luteolin, genistein, dihydroquercetin, daidzein, quercetin, kaempferol, catechin, epicatechin and proanthocyanidins. Among them, apigenin was detected in all the microalgae species, namely, Phaeodactylum tricornutum, Diacronema lutheri, Porphyridium purpureum, Haematococcus pluvialis, C. vulgaris, T. suecica and Arthrospira platensis. H. pluvialis contained most of the flavonoids tested, quercetin, dihydroquercetin, kaempferol, dihydrokaempferol, naringenin, apigenin, luteolin, genistein and daidzein [9].
Seaweeds, especially red and brown algae, are often considered a superfood. Different seaweed species are consumed as food and supplements worldwide. Likewise, eukaryotic microalgae Chlorella spp. and cyanobacteria Spirulina sp. are also now quite popular in the market of food supplements. These edible macro- and microalgae are rich in polyphenols, where one-third is phenolic acids and the rest two-thirds are flavonoids. A study showed that flavonoid, particularly epicatechin, was the most frequently found phenolic compound in commercial algal food products, which was detected in each red and brown seaweeds, as well as in Chlorella pyrenoidosa and Spirulina platensis. Other than this flavonoid, catechin gallate, epicatechin gallate, epigallocatechin, epigallocatechin gallate and pyrocatechol was measured in those algae. However, the most interesting thing is that the antioxidant capacity of these water-soluble compounds (ACW) of brown algae, Eisenia bicyclis, was found more than bilberry, strawberry and kiwi [32]. A very comprehensive study was done by Yoshie et al., where twenty-seven Japanese seaweeds from red, green, brown types were evaluated for their flavonoids contents. They found mainly catechin, epicatechin, epigallocatechin and epigallocatechin gallate in different seaweed species. From their study, catechin was found in most of the red and brown species but detected in the highest in Acetabularia ryukyuensis, which is a green alga [45]. In another study, they found rutin, quercetin, myricetin and two other unique flavonoids, hesperidin and morin. Morin was found in each species. Similarly, hesperidin was also detected in most of the seaweeds, even more than rutin, quercetin and myricetin. The highest amount of hesperidin was detected in A. ryukyuensis, Gracilaria texorii and Gracilaria asiatica [25].

3.1. Flavonol

3.1.1. Rutin

Flavonoid glycoside, rutin (3′,4′,5,7-tetrahydroxy-flavone-3-rutinoside)) is a dietary flavonoid and frequently found in more than seventy plant species. It is also known as vitamin P. Rutin was found in the aerial part of Ruta graveolens and hence, the name was derived from this plant [24]. Rutin is widely found in cyanobacterial species. Microcheate tenera (29.4 ± 0.7 µg/g fresh weight), Mastigocladus laminosus (13.4 ± 0.4 µg/g fresh wt), Anabaena doliolum (12.8 ± 0.41 µg/g fresh wt), Calothrix geitonos (12.0 ± 0.4 µg/g fresh wt) were reported to contain rutin. This cyanobacterial rutin exhibited higher radical scavenging activity compared to BHT and α-Tocoferol [14]. Plectonema boryanum, Hapalosiphon intricatus and Oscillatoria acuta also contain rutin but in lesser amount [13]. Dunaliella tertiolecta also produces rutin but in high ferric concentration, 900 nmol/L and low copper concentration, 315 nmol/L [19].
Rutin kills cancer cells through an increased level of ROS that causes oxidative stress in the cells. It can inhibit PI3K/Akt and Ras/Raf/MAPK signaling pathways that ultimately cause cell cycle arrest and, finally, apoptosis. Upregulation of Bax and downregulation of MMP-2 and Bcl-2 by rutin can also lead to apoptosis through caspase-3 activation. In the animal model, rutin can effectively reduce doxorubicin-induced neurotoxicity and nephrotoxicity [46].

3.1.2. Quercetin

Quercetin, a pentahydroxyflavone, is widely found in vegetables and fruits, like apples, grapes, berries, citrus fruits, onions, broccoli and green tea. Quercetin can be found in algae, Nostoc ellipsosporum (23.8 ± 1.03 µg/g fresh weight), Limnothrix obliqueacuminata (12.4 ± 0.43 µg/g fresh wt), Microcheate tenera (18.4 ± 0.85 µg/g fresh wt). In addition, they can be found in Hapalosiphon fontinalis, Scytonema simplex, Calothrix brevissima, Limnothrix sp. and Phormidium tenue in almost similar amounts (around 11 µg/g fresh wt). Moreover, quercetin showed more potent anti-oxidative activity (IC50 = 4.71 ± 0.49 µg/mL) than α-tocoferol and commercial antioxidant BHT, which was revealed by DPPH radical scavenging assays [14]. It has been reported that quercetin has higher antiradical activity when compared to other phenolics, like rutin and catechol [47].
Quercetin also have strong anticancer activity. Quercetin has been reported to arrest the cell cycle by releasing p53 that augments p21, GADD45 and Bax expression, as well as impedes CDK2, cyclin A and B activity. In addition, it hindered the migration of cancer cells through upregulation of the expression of E-cadherin and downregulation of N-cadherin, Vimentin, MMP-2, -7 and Snail-dependent Akt activation pathway. On top of that quercetin can induce autophagic cell death by modulating LC3Ι. Quercetin induced apoptotic and autophagic cell death in the mouse model as well [48]. Furthermore, quercetin potentiated the efficacy of sorafenib in lower doses in thyroid cancer therapy by increasing the expression of E-cadherin and decreasing the expression of N-cadherin [49].

3.1.3. Kaempferol

Kaempferol (3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) is classed among flavonol and is mostly found in cabbage, broccoli, beans, tomatoes and berries [21]. Kaempferol has been reported to be found in Nostoc and Anabaena, which is 1.08 and 1.23 mg/g of dry wt of the extract with good antioxidant property [15]. Marine microalgae, Nannochloris sp. produced kaempferol in higher amounts, 12.10 ± 1.32 µg/g [22]. Kaempferol is found mostly in M. tenera (7.8 ± 0.7 µg/g fresh wt), Westiellopsis prolific (7.8 ± 0.46 µg/g fresh wt), H. fontinalis (4.8 ± 0.6 µg/g fresh wt), Cylindrospermum sp. (3.9 ± 0.36 µg/g fresh wt). This flavonoid showed stronger antioxidant activity with less IC50 than α-Tocoferol and BHT [14].
Kaempferol can induce apoptosis in ovarian cancer cells through increased expression of apoptotic proteins, caspase-3, -8, -9, Bax, or by stimulating death receptors/FADD/Caspase-8 pathway. In these cancer cells, it stopped the progression of the cell cycle in G2/M phase by inducing the Chk2/Cdc25C/Cdc2 and Chk2/p21/Cdc2 pathways [50,51]. In pancreatic cancer cells, it induced apoptosis by activating tissue transglutaminase (TGM2) mediated Akt/mTOR signaling pathway that increased the ROS production in the cells [52].

3.1.4. Morin

Morin (3,5,7,2’,4’-pentahydroxyflavone) is a unique flavonoid in all types of algae species and the highest amount was reported in green seaweed, Caulerpa serrulata with an amount of 3730 ± 23 µg/g fresh weight. Morin was found in other species of seaweeds like, Monostroma nitidum, Caulerpa racemose, Caulerpa serrulata, Undaria pinnatifida, Eisenia bicyclis, Ishige okamurae, Laminaria religiosa, Porphyra yezoensis and Chondrus verruscosus [25].
Morin exerted anticancer activity against chronic myeloid leukemia via downregulation of the PI3K/AKT signaling pathway and also miR-188-5p which led to apoptosis [53]. In triple-negative breast cancer cells (MDA-MB-231), morin exerted anti-proliferative activity by arresting cells at S and G2/M phase, via upregulation of the ERK/p21 signaling pathway and downregulation of the FOXM1 signaling, which reduced cyclin A2 and cyclin B1 [54]. Another anticancer activity of morin is the downregulation of Glut 1 expression that restricts the entry of glucose into the cells. As glucose is the main nutrient, blocking its uptake leads to mitochondria-mediated apoptosis [55].

3.2. Flavanol

3.2.1. Catechin

Catechin, a flavan-3-ol, is mainly found in Camellia sinensis and C. assumica. Catechin is divided into eight different classes [28]. Catechin has been detected in Euglena cantabrica (71.4 µg/g of dry weight) and these flavonoid-containing extracts have radical scavenging activity [29]. It was also found in Dunaliella tertiolecta, even when exposed to low copper concentration, up to 315 nmol/L [19]. Seaweed, Porphyra tenera produced a high amount of catechin than the microalgae, which was measured as 128.8 ± 2.9 µg/g [32].
Catechin can kill human glioma (U87MG) cells in a concentration-dependent manner while showing lower cytotoxicity in normal astrocytes. It can inhibit cell proliferation by blocking cells in G2/M phase of the cell cycle and also by inhibiting MAPK/ERK signaling pathway. Moreover, catechin can cause autophagy-induced glioma cell death by forming autophagosomes and autophagic vacuoles and triggering increased expression of LC3II and decreased expression of p62 [56]. Nanohybrid formulation with catechin (50 µg/mL) inhibited human melanoma (WM266-4) cells proliferation and new blood vessel formation in zebrafish xenotransplants [57].

3.2.2. Epicatechin

Epicatechin, another flavanol, is subclassed into catechin and was isolated from the pith of the palm Metroxylon sagu. Epicatechin is abundant in green tea and black tea, berries, red wine and cacao. Epicatechin is also found in algae, such as Euglena cantabrica but in small amounts (7.1 µg/g of dry weight) [19]. In addition, epicatechin was found in edible macroalgae, Porphyra tenera but the highest amount was found in Spirulina platensis, at concentration of 27.5 ± 1.3 µg/g [32]. Along with other bioactivities, epicatechin exerts anticancer activity. For example, epicatechin can kill breast cancer (MDA-MB-231 and MCF-7 cells,) cells in a concentration-dependent manner with an IC50 of 350 µM. It can induce apoptosis through DNA fragmentation, augmentation of the expression of pro-apoptotic proteins (Bad and Bax) and an increased level of ROS [58]. Epicatechin can act as a restorative agent which is assumed to mitigate negative side effects of chemotherapy drug, bleomycin and helps improving lung damage which in turn enhances the quality of life of the patient. In the animal model, this flavanol reduced the negative effects of bleomycin by alleviating oxidative stress, inflammation and fibrosis [59].

3.2.3. Epigallocatechin-Gallate (EGCG)

Epigallocatechin-gallate (EGCG) is also classed among catechin and is also mostly found in green tea. An edible seaweed Undaria pinnatifida (also called Wakame in Japanese) has been reported to produce a high amount of EGCG (7.5 ± 0.1 µg/g) and also P. tenera produced this flavonoid but in less amount, 4.0 ± 0.1 µg/g [32]. Among the catechins, EGCG is the most potent anticancer compound. It shows chemo-preventive action against twenty-four different types of cancer [60]. EGCG can inhibit cell proliferation, angiogenesis and metastasis. Moreover, it can kill cancer cells through apoptosis and autophagy [61]. To exert anticancer activity, EGCG modulated different signaling pathways like JAK2/STAT3/AKT, VEGF/VEGFR. TGF/SMAD, Wnt/β-catenin, Notch pathway and TRAIL-mediated pathway [62].

3.3. Flavone

3.3.1. Apigenin

Apigenin (4′,5,7-trihydroxyflavone) is a flavone and widespread in different plant species. A high amount of apigenin was found in the biomass methanol extract of cyanobacteria Leptolyngbya sp., which was 0.4 ± 0.02 mg/g and this methanol extract showed the highest radical scavenging activity [27].
Apigenin can kill different kinds of cancer cells. In breast cancer cell line MCF-7, apigenin can induce apoptosis through increased ROS production and DNA fragmentation. In addition, it can enhance the expression of p53, Bax/Bcl-2 ratio, caspase proteins and thus, influencing the cleavage of PARP. Apigenin can arrest cells at G2/M phase as well [63]. In cisplatin-resistant colon cancer cells HT-29, apigenin can augment the expression of Beclin-1 and LC3-II and downregulate the expression of p62 which leads to autophagic death. It can also induce apoptosis by increasing Bax expression while downregulating Bcl-2 expression in the same cell line [64].

3.3.2. Dimethoxyflavon

Marine microalgae Phaeodactylum tricornutum, Nannochloris sp. and Tetraselmis suecica from Mediterranean Morocco have been reported to produce dimethoxyflavon. Among them, P. tricornutum has the highest amount of dimethoxyflavon, 28.38 ± 2.90 µg/g [22].
In a study, dimethoxyflavone induced apoptosis in endometrioma cells by inhibiting PI3K/AKT and ERK1/2 signaling pathways, activating ER-stress response proteins and MAPK proteins, JNK and p38, increasing the production of ROS and calcium in high levels which led to disruption of mitochondrial membrane potential while inactivating the PI3K/MAPK pathways [65].

3.4. Isoflavone

Genistein

Genistein [5,7-dihydroxy-3-(4-hydroxyphenyl) chromen-4-one] is classed among isoflavones. It was first discovered in Genista tinctoria and thus, named after this plant. It is found in leguminous plants, mainly in soybean. However, genistein is not quite common in algae species. Goiri et al. reported the highest level of genistein in Phaeodactylum tricornutum, 1.42 ± 0.14 ng/g [9].
Cancer cells are affected by genistein via apoptosis induction, cell cycle arrest, inhibition of metastasis and angiogenesis. To induce apoptotic death, genistein hindered NF-κB pathways and upregulates pro-apoptotic proteins like, Bax, Bad and Bak, as well as cyt c release which in turn caused caspase-dependent apoptosis. Genistein also induced calpain which is a Ca2+ dependent protein that is responsible for cleaving Bax and Bid, rendering apoptotic cell death. Genistein can impede the cell cycle by modulating Ras/MAPK/activator protein-1 and downregulating the expression of Cdk1, cyclin B1 and Cdc25C. Moreover, genistein inhibited angiogenesis through reduced expression of VEGF, MMP-2/9 and JNK, p38, PTK/MAPK pathways [37].

3.5. Flavanone

Hesperidin

Hesperidin (3′,5,7-trihydroxy-4′-methoxyflavanone-7-rhamnoglucoside) is a bioflavonoid that is mainly found in citrus fruits, especially orange and lemon [39]. Hesperidin is mostly found in red algae. In a study of Japanese seaweed flavonoid content, Gracilaria texorii was found to have the highest amount of hesperidin, 119,000 ± 1800 µg/g fresh weight [25].
Hesperidin exerts its anticancer activity against different cancer cells. In MDA-MB231 breast cancer cells, it can inhibit metastasis of these cells by downregulation of the expression of programmed death-ligand 1 (PD-L1) with reduced expression of Akt and NF-κB signaling and also decrease in the expression of MMP-9 and MMP-2 [66]. A study showed that co-administration with imatinib mesylate, hesperidin potentiated the drug action on the imatinib-resistant breast cancer cells and also with less negative effects. It downregulated the expression of the multidrug-resistant (MDR-1) gene, thus, overcome the drug resistance. Hesperidin upregulated Bax/Bcl-2 and caspase-3 expression to induce apoptosis. In addition, it protected heart tissue which was revealed through the reduced serum enzymes LDH and SGOT [67].

4. Prospects and Limitations

Flavonoids are an excellent reservoir of biological activities that can be exploited to treat different medical conditions, for instance, diabetes, cardiovascular dysfunction, ocular diseases, aging problem and neurological complications. Some clinical trials also proved the efficiency of using flavonoids in different kinds of health-related problems. However, utilizing flavonoids in the drug discovery process have some major concerns. Flavonoids present in a very small amount in plants or algae, from µg to mg per kg of biomass. Moreover, this small amount is mostly found in complex with other bioactive compounds, which renders it difficult to determine the actual source of the pharmacological effect. Purification and identification of these flavonoids are a multistage, expensive and time-consuming process. In addition, their high lability and being prone to chemical alteration can lead to degradation during the purification process. Poor bioavailability is another problem for flavonoids as a drug. However, with novel optimization techniques, multiplex purification systems and metabolic engineering, flavonoids can be extracted in a high amount from natural sources. However, another most important problem for plant flavonoids is that a regular and high amount of extraction from plant species may cause the elimination of useful plant species or may risk food security [68]. Algae, as a potential source of flavonoids, offer a suitable solution for this problem.
Microalgae give several benefits over higher plants in the production of high-value products. The fast and foremost benefit of microalgae is their high photosynthetic efficiency than terrestrial plants, which is linked to their fast growth rate and high yield per unit dry biomass than plants. Moreover, microalgae can be grown in ranges of water media; saltwater, freshwater and even wastewater. Industrial effluent or aquaculture wastewater can be an alternative source of media for the economic production of microalgae [69]. Moreover, microalgae are now grown in large photobioreactors which limits vast land-use and contamination risk. Microalgae and seaweed farming don’t have any impact on food security and the environment, as no chemical fertilizer is used in the cultivation process. Specialized photobioreactors provide optimum and evenly distributed illumination to the microalgae culture which is important for a high production rate. Though this sophisticated bioreactor is a bit expensive. Efficient and low-cost harvesting is another challenge to get high-value compounds from microalgae. In recent years, membrane bioreactors are in use for harvesting microalgae which is a cheaper but efficient harvesting alternative. The system called magnetically induced membrane vibration makes this harvesting process more easier and cost-effective [70]. Therefore, to get benefit from these excellent species, a suitable and effective separation technique along with extensive anticancer study is warranted for algal flavonoids.

5. Conclusions

Microalgae and seaweeds are both suitable sources of different classes of flavonoids. However, the anticancer study from such valuable sources is overlooked. Though studies predicted that the total flavonoid contents found in the microalgae species is responsible for the antitumor activity in various cell lines, further purification and identification have not been done yet. More emphasis should be put on the isolation of specific flavonoids from algal sources and their bioactive properties. Moreover, seaweed and marine microalgae may possess unique flavonoid types, which can further be revealed through marine bioprospecting. Thus, algae can become an alternative source of flavonoids with anticancer activity.

Author Contributions

Conceptualization, U.T.F. and Z.N.B.Y.; writing—original draft preparation, U.T.F.; writing—review and editing, Z.N.B.Y.; funding acquisition, Z.N.B.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research is supported by Higher Institution Centre of Excellence (HICOE) Research Grant (Innovative Vaccines and Therapeutics against Fish Diseases) (Project No. 6369100) and SATREPS (JICA-JST): COSMOS-MOHE G4-B Research Grant (Microalgae for Sustainable Aquaculture Health: Microalgae Vaccine Delivery System) (Project No. 6300866).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA. Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef]
  2. Dehelean, C.A.; Marcovici, I.; Soica, C.; Mioc, M.; Coricovac, D.; Iurciuc, S.; Cretu, O.M.; Pinzaru, I. Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy. Molecules 2021, 26, 1109. [Google Scholar] [CrossRef]
  3. Ruiz-Torres, V.; Encinar, J.A.; Herranz-López, M.; Pérez-Sánchez, A.; Galiano, V.; Barrajón-Catalán, E.; Micol, V. An updated review on marine anticancer compounds: The use of virtual screening for the discovery of small-molecule cancer drugs. Molecules 2017, 22, 1037. [Google Scholar] [CrossRef] [PubMed]
  4. Zuo, W.; Kwok, H.F. Development of Marine-Derived Compounds for Cancer Therapy. Mar. Drugs 2021, 19, 342. [Google Scholar] [CrossRef]
  5. Saeed, A.F.U.H.; Su, J.; Ouyang, S. Marine-derived drugs: Recent advances in cancer therapy and immune signaling. Biomed. Pharmacother. 2021, 134, 111091. [Google Scholar] [CrossRef]
  6. Martínez Andrade, K.A.; Lauritano, C.; Romano, G.; Ianora, A. Marine microalgae with anti-cancer properties. Mar. Drugs 2018, 16, 165. [Google Scholar] [CrossRef] [Green Version]
  7. Abd El-Hack, M.E.; Abdelnour, S.; Alagawany, M.; Abdo, M.; Sakr, M.A.; Khafaga, A.F.; Mahgoub, S.A.; Elnesr, S.S.; Gebriel, M.G. Microalgae in modern cancer therapy: Current knowledge. Biomed. Pharmacother. 2019, 111, 42–50. [Google Scholar] [CrossRef]
  8. Gong, M.; Bassi, A. Carotenoids from microalgae: A review of recent developments. Biotechnol. Adv. 2016, 34, 1396–1412. [Google Scholar] [CrossRef] [PubMed]
  9. Goiris, K.; Muylaert, K.; Voorspoels, S.; Noten, B.; Baart, G.J.E. Detection of flavonoids in microalgae from different evolutionary lineages. J. Phycol. 2014, 50, 483–492. [Google Scholar] [CrossRef]
  10. Bisol, Â.; de Campos, P.S.; Lamers, M.L. Flavonoids as anticancer therapies: A systematic review of clinical trials. Phyther. Res. 2020, 34, 568–582. [Google Scholar] [CrossRef] [PubMed]
  11. Falcone Ferreyra, M.L.; Rius, S.P.; Casati, P. Flavonoids: Biosynthesis, biological functions, and biotechnological applications. Front. Plant Sci. 2012, 3, 222. [Google Scholar] [CrossRef] [Green Version]
  12. Salehi, B.; Fokou, P.V.T.; Sharifi-Rad, M.; Zucca, P.; Pezzani, R.; Martins, N.; Sharifi-Rad, J. The therapeutic potential of naringenin: A review of clinical trials. Pharmaceuticals 2019, 12, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Singh, D.P.; Prabha, R.; Meena, K.K.; Sharma, L.; Sharma, A.K. Induced Accumulation of Polyphenolics and Flavonoids in Cyanobacteria under Salt Stress Protects Organisms through Enhanced Antioxidant Activity. Am. J. Plant Sci. 2014, 5, 726–735. [Google Scholar] [CrossRef]
  14. Singh, D.P.; Prabha, R.; Verma, S.; Meena, K.K.; Yandigeri, M. Antioxidant properties and polyphenolic content in terrestrial cyanobacteria. 3 Biotech 2017, 7, 134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Babić, O.; Kovač, D.; Rašeta, M.; Šibul, F.; Svirčev, Z.; Simeunović, J. Evaluation of antioxidant activity and phenolic profile of filamentous terrestrial cyanobacterial strains isolated from forest ecosystem. J. Appl. Phycol. 2016, 28, 2333–2342. [Google Scholar] [CrossRef]
  16. Bhuvana, P.; Sangeetha, P.; Anuradha, V.; Ali, M.S. Spectral characterization of bioactive compounds from microalgae: N. Oculata and C. Vulgaris. Biocatal. Agric. Biotechnol. 2019, 19, 101094. [Google Scholar] [CrossRef]
  17. Abd El-Baky, H.H.; El Baz, F.K.; El-Baroty, G.S. Production of phenolic compounds from Spirulina maxima microalgae and its protective effects in vitro toward hepatotoxicity model. Afr. J. Pharm. Pharmacol. 2009, 3, 133–139. [Google Scholar]
  18. Salehi, B.; Machin, L.; Monzote, L.; Sharifi-Rad, J.; Ezzat, S.M.; Salem, M.A.; Merghany, R.M.; El Mahdy, N.M.; Klllç, C.S.; Sytar, O.; et al. Therapeutic potential of quercetin: New insights and perspectives for human health. ACS Omega 2020, 5, 11849–11872. [Google Scholar] [CrossRef] [PubMed]
  19. López, A.; Rico, M.; Santana-Casiano, J.M.; González, A.G.; González-Dávila, M. Phenolic profile of Dunaliella tertiolecta growing under high levels of copper and iron. Environ. Sci. Pollut. Res. 2015, 22, 14820–14828. [Google Scholar] [CrossRef] [PubMed]
  20. Park, K.S.; Chong, Y.; Kim, M.K. Myricetin: Biological activity related to human health. Appl. Biol. Chem. 2016, 59, 259–269. [Google Scholar] [CrossRef]
  21. Silva dos Santos, J.; Gonçalves Cirino, J.P.; de Oliveira Carvalho, P.; Ortega, M.M. The Pharmacological Action of Kaempferol in Central Nervous System Diseases: A Review. Front. Pharmacol. 2021, 11, 565700. [Google Scholar] [CrossRef]
  22. Haoujar, I.; Cacciola, F.; Abrini, J.; Mangraviti, D.; Giu, D.; Oulad, Y.; Majdoub, E.; Kounnoun, A.; Miceli, N.; Taviano, M.F.; et al. The Contribution of Carotenoids, Phenolic Compounds, and Flavonoids to the Antioxidative Properties of Marine Microalgae Isolated from Mediterranean Morocco. Molecules 2019, 24, 4037. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Ibitoye, O.B.; Uwazie, J.N.; Ajiboye, T.O. Bioactivity-guided isolation of kaempferol as the antidiabetic principle from Cucumis sativus L. fruits. J. Food Biochem. 2018, 42, e12479. [Google Scholar] [CrossRef]
  24. Prasad, R.; Prasad, S.B. Antitumor Activity of Rutin-Cisplatin in Combination and Its Protective Effect Against Hematotoxicity. Res. J. Life. Sci. Bioinform. Pharm. Chem. Sci. 2018, 4, 42–56. [Google Scholar] [CrossRef]
  25. Yoshie-Stark, Y.; Hsieh, Y.P.; Suzuki, T. Distribution of flavonoids and related compounds from seaweeds in Japan. J. Tokyo Univ. Fish. 2003, 89, 1–6. [Google Scholar]
  26. Rajput, S.A.; Wang, X.; Yan, H. Morin hydrate: A comprehensive review on novel natural dietary bioactive compound with versatile biological and pharmacological potential. Biomed. Pharmacother. 2021, 138, 111511. [Google Scholar] [CrossRef]
  27. Trabelsi, L.; Mnari, A.; Abdel-Daim, M.M.; Abid-Essafi, S.; Aleya, L. Therapeutic properties in Tunisian hot springs: First evidence of phenolic compounds in the cyanobacterium Leptolyngbya sp. biomass, capsular polysaccharides and releasing polysaccharides. BMC Complement. Altern. Med. 2016, 16, 515. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Bae, J.; Kim, N.; Shin, Y.; Kim, S.-Y.; Kim, Y.-J. Activity of catechins and their applications. Biomed. Dermatol. 2020, 4, 8. [Google Scholar] [CrossRef] [Green Version]
  29. Jerez-Martel, I.; García-Poza, S.; Rodríguez-Martel, G.; Rico, M.; Afonso-Olivares, C.; Gómez-Pinchetti, J.L. Phenolic profile and antioxidant activity of crude extracts from microalgae and cyanobacteria strains. J. Food Qual. 2017, 2017, 2924508. [Google Scholar] [CrossRef] [Green Version]
  30. Yadavalli, R.; Peasari, J.R.; Mamindla, P.; Praveenkumar; Mounika, S.; Ganugapati, J. Phytochemical screening and in silico studies of flavonoids from Chlorella pyrenoidosa. Inform. Med. Unlocked 2018, 10, 89–99. [Google Scholar] [CrossRef]
  31. Blagojević, D.; Babić, O.; Rašeta, M.; Šibul, F.; Janjušević, L.; Simeunović, J. Antioxidant activity and phenolic profile in filamentous cyanobacteria: The impact of nitrogen. J. Appl. Phycol. 2018, 30, 2337–2346. [Google Scholar] [CrossRef]
  32. Machu, L.; Misurcova, L.; Ambrozova, J.V.; Orsavova, J.; Mlcek, J.; Sochor, J.; Jurikova, T. Phenolic content and antioxidant capacity in algal food products. Molecules 2015, 20, 1118–1133. [Google Scholar] [CrossRef] [Green Version]
  33. Das, S.; Tanwar, J.; Hameed, S.; Fatima, Z. Antimicrobial potential of epigallocatechin-3-gallate (EGCG): A green tea polyphenol. J. Biochem. Pharmacol. Res. 2014, 2, 167–174. [Google Scholar]
  34. Salehi, B.; Venditti, A.; Sharifi-rad, M.; Kr, D.; Sharifi-rad, J.; Durazzo, A.; Lucarini, M.; Santini, A.; Souto, E.B.; Novellino, E.; et al. The therapeutic potential of apigenin. Int. J. Mol. Sci 2019, 20, 1305. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Imran, M.; Rauf, A.; Abu-Izneid, T.; Nadeem, M.; Shariati, M.A.; Khan, I.A.; Imran, A.; Orhan, I.E.; Rizwan, M.; Atif, M.; et al. Luteolin, a flavonoid, as an anticancer agent: A review. Biomed. Pharmacother. 2019, 112, 108612. [Google Scholar] [CrossRef] [PubMed]
  36. Yenjai, C.; Wanich, S.; Pitchuanchom, S.; Sripanidkulchai, B. Structural modification of 5,7-dimethoxyflavone from Kaempferia parviflora and biological activities. Arch. Pharm. Res. 2009, 32, 1179–1184. [Google Scholar] [CrossRef] [PubMed]
  37. Tuli, H.S.; Tuorkey, M.J.; Thakral, F.; Sak, K.; Kumar, M.; Sharma, A.K.; Sharma, U.; Jain, A.; Aggarwal, V.; Bishayee, A. Molecular mechanisms of action of genistein in cancer: Recent advances. Front. Pharmacol. 2019, 10, 1336. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Sun, M.Y.; Ye, Y.; Xiao, L.; Rahman, K.; Xia, W.; Zhang, H. Daidzein: A review of pharmacological effects. Afr. J. Tradit. Complement. Altern. Med. 2016, 13, 117–132. [Google Scholar] [CrossRef] [Green Version]
  39. Stanisic, D.; Costa, A.F.; Favaro, W.J.; Tasic, L.; Seabra, A.B.; Duran, N. Anticancer Activities of Hesperidin and Hesperetin In vivo and their Potentiality against Bladder Cancer. J. Nanomed. Nanotechnol. 2018, 9, 1000515. [Google Scholar] [CrossRef]
  40. El-hadad, S.S.; Tikhomirova, N.A.; El-aziz, M.A. Biological activities of dihydroquercetin and its effect on the oxidative stability of butter oil. J. Food Process. Preserv 2020, 44, e14519. [Google Scholar] [CrossRef]
  41. Brodowska, K.M. Natural flavonoids: Classification, potential role, and application of flavonoid analogues. Eur. J. Biol. Res. 2017, 7, 108–123. [Google Scholar]
  42. Kopustinskiene, D.M.; Jakstas, V.; Savickas, A.; Bernatoniene, J. Flavonoids as anticancer agents. Nutrients 2020, 12, 457. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. El-baky, H.H.A.; El-Baz, F.K.; El-baroty, G.S. Production of phenolic compounds from Spirulina maxima microalgae. Afr. J. Biotechnol. 2009, 8, 7059–7067. [Google Scholar]
  44. Yadavalli, R.; Ratnapuram, H.; Motamarry, S.; Reddy, C.N.; Ashokkumar, V.; Kuppam, C. Simultaneous production of flavonoids and lipids from Chlorella vulgaris and Chlorella pyrenoidosa. Biomass Convers. Biorefin. 2020, 1–9. [Google Scholar] [CrossRef]
  45. Yoshie, Y.; Wang, W.; Petillo, D.; Suzuki, T. Distribution of catechins in Japanese seaweeds. Fish. Sci. 2000, 66, 998–1000. [Google Scholar] [CrossRef]
  46. Imani, A.; Maleki, N.; Bohlouli, S.; Kouhsoltani, M.; Sharifi, S.; Maleki Dizaj, S. Molecular mechanisms of anticancer effect of rutin. Phyther. Res. 2021, 35, 2500–2513. [Google Scholar] [CrossRef]
  47. Oliveira, S.; Souza, G.A.; Eckert, C.R.; Silva, T.A.; Edmar Silva Sobra, E.S.; Fávero, O.P.; Ferreira, M.J.P.; Romoff, P.; Baader, W. Evaluation of Antiradical Assays Used in Determining The Antioxidant Capacity of Pure Compounds And Plant Extracts. Quim. Nov. 2014, 37, 497–503. [Google Scholar] [CrossRef]
  48. Tang, S.M.; Deng, X.T.; Zhou, J.; Li, Q.P.; Ge, X.X.; Miao, L. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed. Pharmacother. 2020, 121, 109604. [Google Scholar] [CrossRef]
  49. Celano, M.; Maggisano, V.; Bulotta, S.; Allegri, L.; Pecce, V.; Abballe, L.; Damante, G.; Russo, D. Quercetin improves the effects of sorafenib on growth and migration of thyroid cancer cells. Endocrine 2020, 67, 496–498. [Google Scholar] [CrossRef]
  50. Gao, Y.; Yin, J.; Rankin, G.O.; Chen, Y.C. Kaempferol induces G2/M cell cycle arrest via checkpoint kinase 2 and promotes apoptosis via death receptors in human ovarian carcinoma A2780/CP70 Cells. Molecules 2018, 23, 1095. [Google Scholar] [CrossRef] [Green Version]
  51. Yang, S.; Si, L.; Jia, Y.; Jian, W.; Yu, Q.; Wang, M.; Lin, R. Kaempferol exerts anti-proliferative effects on human ovarian cancer cells by inducing apoptosis, G0/G1 cell cycle arrest and modulation of MEK/ERK and STAT3 pathways. JBUON 2019, 24, 975–981. [Google Scholar]
  52. Wang, F.; Wang, L.; Qu, C.; Chen, L.; Geng, Y.; Cheng, C.; Yu, S.; Wang, D.; Yang, L.; Meng, Z.; et al. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. BMC Cancer 2021, 21, 396. [Google Scholar] [CrossRef]
  53. Nie, Z.Y.; Yang, L.; Liu, X.J.; Yang, Z.; Yang, G.S.; Zhou, J.; Qin, Y.; Yu, J.; Jiang, L.L.; Wen, J.K.; et al. Morin inhibits proliferation and induces apoptosis by modulating the MIR-188-5p/PTEN/Akt regulatory pathway in CML cells. Mol. Cancer Ther. 2019, 18, 2296–2307. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Maharjan, S.; Kwon, Y.S.; Lee, M.G.; Lee, K.S.; Nam, K.S. Cell cycle arrest-mediated cell death by morin in MDA-MB-231 triple-negative breast cancer cells. Pharmacol. Rep. 2021, 1–13. [Google Scholar] [CrossRef]
  55. Sithara, T.; Arun, K.B.; Syama, H.P.; Reshmitha, T.R.; Nisha, P. Morin inhibits proliferation of SW480 colorectal cancer cells by inducing apoptosis mediated by reactive oxygen species formation and uncoupling of warburg effect. Front. Pharmacol. 2017, 8, 640. [Google Scholar] [CrossRef] [Green Version]
  56. Sheng, Z.Z. Anticancer effects of catechin flavonoid in human glioma cells are mediated via autophagy induction, cell cycle arrest, inhibition of cell migration and invasion and targeting MAPK/ ERK signalling pathway. J. BU ON 2020, 25, 1084–1090. [Google Scholar]
  57. di Leo, N.; Battaglini, M.; Berger, L.; Giannaccini, M.; Dente, L.; Hampel, S.; Vittorio, O.; Cirillo, G.; Raffa, V. A catechin nanoformulation inhibits WM266 melanoma cell proliferation, migration and associated neo-angiogenesis. Eur. J. Pharm. Biopharm. 2017, 114, 1–10. [Google Scholar] [CrossRef] [PubMed]
  58. Pereyra-Vergara, F.; Olivares-Corichi, I.M.; Perez-Ruiz, A.G.; Luna-Arias, J.P.; García-Sánchez, J.R. Apoptosis induced by (−)-epicatechin in human breast cancer cells is mediated by reactive oxygen species. Molecules 2020, 25, 1025. [Google Scholar] [CrossRef] [Green Version]
  59. Shariati, S.; Kalantar, H.; Pashmforosh, M.; Mansourif, E.; Khodayar, M.J. Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice. Biomed. Pharmacother. 2019, 114, 108776. [Google Scholar] [CrossRef]
  60. Almatrood, S.A.; Almatroudi, A.; Khan, A.A.; Alhumaydh, F.A.; Alsahl, M.A.; Rahmani, A.H. Potential therapeutic targets of epigallocatechin gallate (EGCG), the most abundant catechin in green tea, and its role in the therapy of various types of cancer. Molecules 2020, 25, 3146. [Google Scholar] [CrossRef]
  61. Huang, Y.J.; Wang, K.L.; Chen, H.Y.; Chiang, Y.F.; Hsia, S.M. Protective effects of epigallocatechin gallate (EGCG) on endometrial, breast, and ovarian cancers. Biomolecules 2020, 10, 1481. [Google Scholar] [CrossRef]
  62. Farooqi, A.A.; Pinheiro, M.; Granja, A.; Farabegoli, F.; Reis, S.; Attar, R.; Sabitaliyevich, U.Y.; Xu, B.; Ahmad, A. EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways. Cancers 2020, 12, 951. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Shendge, A.K.; Chaudhuri, D.; Basu, T.; Mandal, N. A natural flavonoid, apigenin isolated from Clerodendrum viscosum leaves, induces G2/M phase cell cycle arrest and apoptosis in MCF-7 cells through the regulation of p53 and caspase-cascade pathway. Clin. Transl. Oncol. 2021, 23, 718–730. [Google Scholar] [CrossRef] [PubMed]
  64. Chen, X.; Xu, H.; Yu, X.; Wang, X.; Zhu, X.; Xu, X. Apigenin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant colon cancer cells by inducing autophagy, programmed cell death and targeting m-TOR/PI3K/Akt signalling pathway. J. BU ON 2019, 24, 488–493. [Google Scholar]
  65. Park, W.; Park, M.Y.; Song, G.; Lim, W. 5,7-Dimethoxyflavone induces apoptotic cell death in human endometriosis cell lines by activating the endoplasmic reticulum stress pathway. Phyther. Res. 2020, 34, 2275–2286. [Google Scholar] [CrossRef]
  66. Kongtawelert, P.; Wudtiwai, B.; Shwe, T.H.; Pothacharoen, P.; Phitak, T. Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer. Molecules 2020, 25, 252. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. El-Sisi, A.E.; Sokkar, S.S.; Ibrahim, H.A.; Hamed, M.F.; Abu-Risha, S.E. Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity. Fundam. Clin. Pharmacol. 2020, 34, 458–475. [Google Scholar] [CrossRef]
  68. Amawi, H.; Ashby, C.R.; Tiwari, A.K. Cancer chemoprevention through dietary flavonoids: What’s limiting? Chin. J. Cancer 2017, 36, 50. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Dębowski, M.; Zieliński, M.; Kazimierowicz, J.; Kujawska, N.; Talbierz, S. Microalgae cultivation technologies as an opportunity for bioenergetic system development—advantages and limitations. Sustainability 2020, 12, 9980. [Google Scholar] [CrossRef]
  70. Zhao, Z.; Mertens, M.; Li, Y.; Muylaert, K.; Vankelecom, I.F.J. A highly efficient and energy-saving magnetically induced membrane vibration system for harvesting microalgae. Bioresour. Technol. 2020, 300, 122688. [Google Scholar] [CrossRef] [PubMed]
Molecules 26 06844 g001 550
Figure 1. Biological function of flavonoids [11,12].
Figure 1. Biological function of flavonoids [11,12].
Molecules 26 06844 g001
Molecules 26 06844 g002 550
Figure 2. Chemical structure of commonly found flavonoids.
Figure 2. Chemical structure of commonly found flavonoids.
Molecules 26 06844 g002
Table
Table 1. Sources of algal flavonoids and their possible anticancer activity.
Table 1. Sources of algal flavonoids and their possible anticancer activity.
SubclassFlavonoids Algae Source Amount Possible Bioactivity Reference
FlavonolQuercetin Nostoc ellipsosporum23.8 ± 1.03 µg/g fresh wtAnticancer, Antioxidant, Antimicrobial, Antidiabetic, anti-inflammatory,
Neuroprotective,
Hepatoprotective		[13,14,15,16,17,18]
Microcheate tenera18.4 ± 0.85 µg/g fresh wt
Limnothrix
obliqueacuminata		12.4 ± 0.43 µg/g fresh wt
Hapalosiphon fontinalis11.7 ± 0.66 µg/g fresh wt
MyricetinDunaliella tertiolecta6.5 ± 0.6 attomol/cellAnticancer, antidiabetic, anti-infectious, antioxidant, anti-inflammatory, anti-obesity, neuroprotective[19,20]
Tubinaria ornata346 ± 3.4 µg/g
KaempferolNannochloris sp.12.10 ± 1.32 µg/g Anticancer, Antioxidant, Anti-inflammatory, Antidiabetic, Neuroprotective[14,15,21,22,23]
Microcheate tenera7.8 ± 0.7 µg/g fresh wt
Nostoc ellipsosporum4.3 ± 0.6 µg/g fresh wt
Hapalosiphon fontinalis.4.8 ± 0.6 µg/g fresh wt
Westiellopsis prolific7.8 ± 0.46 µg/g fresh wt
RutinMicrocheate tenera29.4 ± 0.72 µg/gAnticancer, antioxidant, antimicrobial, antidiabetic, anti
Inflammatory,
neuroprotective,
cardioprotective, hepatoprotective, nephroprotective		[13,14,15,19,24]
Dunaliella tertiolecta2.8 ± 0.3 attomol/cell
Hapalosiphon intricatus9.61 µg/g fresh wt
Calothrix geitonos12.0 ± 0.4 µg/g fresh wt
Mastigocladus laminosus13.4 ± 0.46 µg/g fresh wt
Lyngbya sp.8.8 ± 0.6 µg/g fresh wt
Phormidium8.8 ± 0.6 µg/g
Nostoc sp.4.52 mg/g
Morin Caulerpa serrulata3730 ± 23 µg/gAnticancer, antioxidant, anti-microbial, antidiabetic, neuroprotective, anti-arthritis, anti-inflammatory, nephroprotective, cardio protective, hepatoprotective[25,26]
FlavanolCatechinPorphyra tenera128.8 ± 2.9 µg/gAnticancer, Antioxidant,
Antimicrobial, Anti-allergenic, anti-inflammatory, UV protection activity		[19,27,28,29,30,31]
Spirulina platensis22.7 ± 2.3 µg/g
Nannochloris sp.33.47 ± 3.14 µg/g
Dunaliella tertiolecta36.1 ± 0.8 attomol/cell
Euglena cantabrica71.4 µg/g
Leptolyngbya sp.2.6 ± 0.2 mg/g
Anabaena sp.35.19 µg/g
DW
EpicatechinDunaliella tertiolecta24.4 ± 0.1 attomol/cellAnticancer, Antioxidant,
Antidiabetic, anti-inflammatory, Cardio-protective, Neuroprotective		[19,29,30]
Spirulina platensis27.5 ± 1.3 µg/g
Porphyra tenera16.4 ± 0.7 µg/g
Hizikia
fusiformis		8.2 ± 0.1 µg/g
Epigallocatechin-gallateUndaria pinnatifida7.5 ± 0.1 µg/gAnticancer, Antioxidant,
Antimicrobial,
Anti-allergic,
Antidiabetic, anti-inflammatory, Cardio-protective, Neuroprotective		[32,33]
Porphyra tenera4.0 ± 0.1 µg/g
FlavoneApigeninLeptolyngbya sp.0.4 ± 0.02 mg/gAnticancer, antidiabetic, neuroprotective, anti-arthritis, anti-depressant, anti-inflammatory[27,34]
Luteolin-7-glucosideDiacronema lutheri0.8 ± 0.06 ng/gAnticancer, anti-inflammation, anti-allergy and antioxidant[9,27,35]
Leptolyngbya sp.0.4 ± 0.01 mg/g
DimethoxyflavonPhaeodactylum tricornutum28.38 ± 2.90 µg/gAnticancer, antifungal[22,36]
Tetraselmis suecica19.01 ± 1.58 µg/g
IsoflavoneGenisteinPhaeodactylum tricornutum1.42 ± 0.14 ng/g Anticancer, Antioxidant,
Antimicrobial, Antidiabetic, Cardioprotective 		[9,37]
DaidzeinPhaeodactylum tricornutum5.9 ± 0.6 ng/gAnticancer, antidiabetic, Anti-Osteoporosis, anti-aging, antioxidant, anti-microbial, anti-inflammatory[9,38]
FlavanoneNaringeninLeptolyngbya sp.4.1 ± 0.01 mg/gAnticancer, antioxidant, antimicrobial, anti-inflammatory, antiadipogenic, anti-diabetic, cardioprotective, eye-protective[9,12,27]
Diacronema lutheri0.60 ± 0.06 ng/g
HesperidinGracilaria texorii119000 ± 1800 µg/gAnticancer, anti-allergic, anti-oxidant and anti-inflammatory[25,39]
FlavanonolDihydroquercetinHaematococcus pluvialis1.6 ± 0.16 ng/gAnticancer, antioxidant, anti-bacterial[9,30,40]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ferdous, U.T.; Balia Yusof, Z.N. Insight into Potential Anticancer Activity of Algal Flavonoids: Current Status and Challenges. Molecules 2021, 26, 6844. https://doi.org/10.3390/molecules26226844

AMA Style

Ferdous UT, Balia Yusof ZN. Insight into Potential Anticancer Activity of Algal Flavonoids: Current Status and Challenges. Molecules. 2021; 26(22):6844. https://doi.org/10.3390/molecules26226844

Chicago/Turabian Style

Ferdous, Umme Tamanna, and Zetty Norhana Balia Yusof. 2021. "Insight into Potential Anticancer Activity of Algal Flavonoids: Current Status and Challenges" Molecules 26, no. 22: 6844. https://doi.org/10.3390/molecules26226844

Article Metrics

Back to TopTop